Semisynthetic Derivatives of Polygodial as α-Glucosidase and α-Amylase Inhibitors: In Vitro Evaluation, Molecular Docking and Molecular Dynamics Simulation
Pharmaceutics · 05.08.2026 · 18 (8) · 960
DOI: 10.3390/pharmaceutics18080960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 05.08.2026. Verfasst von Viviana Burgos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Tecnología Médica, Facultad de Salud, Universidad Santo Tomás, Temuco 4780000, Chile. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANID Chile, Fondequip Chile.
Abstract (Originalsprache)
Background
Polygodial (9), a drimane sesquiterpene dialdehyde from Drimys winteri, has not previously been examined against carbohydrate-hydrolyzing enzymes.
Methods
Regioselective Wittig olefination at C12 gave the enoate 10; reduction of the remaining C11 aldehyde with NaBH4 was followed by spontaneous intramolecular conjugate addition, affording the annellated tetrahydrofuran 12a and the bridged ether 12b.
Results
All three derivatives inhibited α-glucosidase and α-amylase more strongly than the parent compound. Compound 12a was the most active α-glucosidase inhibitor (IC50 = 53.98 ± 3.0 µM, against 90.36 ± 4.0 µM for acarbose) and, in docking, the only derivative to occupy the acarbose-binding site of the enzyme (−8.1 kcal/mol). However, this 12a–α-glucosidase pose was not maintained during the 200 ns simulations. The enoate 10 was the most active α-amylase inhibitor (IC50 = 42.32 ± 2.1 µM, against 78.24 ± 3.9 µM for acarbose; −8.5 kcal/mol). Over 200 ns of molecular dynamics, the 10–α-amylase complex remained associated, with binding attributed by MM-GBSA mainly to van der Waals and lipophilic terms.
Conclusions
Converting the dialdehyde into an enoate or a cyclic ether increases carbohydrase inhibition and determines which of the two enzymes is preferentially inhibited.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Escuela de Tecnología Médica, Facultad de Salud, Universidad Santo Tomás, Temuco 4780000, Chile.
- Departamento de Ciencias Biológicas y Químicas, Facultad de Recursos Naturales, Universidad Católica de Temuco, Rudecindo Ortega, Temuco 4780000, Chile.
- Laboratory of Natural Products & Drug Discovery, Department of Basic Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4780000, Chile.
- Institut für Chemie, Universität Potsdam, Karl-Liebknecht-Str. 24-25, D-14476 Potsdam, Germany.
ORCID-Profile: Cecilia Villegas, Bernd Schmidt, Vaderament-Alexe Nchiozem-Ngnitedem, Muhammad Javid Iqbal, Cristian Paz
Förderung
- ANID Chile
- Fondequip Chile
Zitieren
APA
Burgos, V., Villegas, C., Sanzana, C., Oporto, B., Schmidt, B., Nchiozem-Ngnitedem, V. A., Iqbal, M. J., & Paz, C. (2026). Semisynthetic Derivatives of Polygodial as α-Glucosidase and α-Amylase Inhibitors: In Vitro Evaluation, Molecular Docking and Molecular Dynamics Simulation. Pharmaceutics, 18(8), 960. https://doi.org/10.3390/pharmaceutics18080960
Vancouver
Burgos V, Villegas C, Sanzana C, Oporto B, Schmidt B, Nchiozem-Ngnitedem VA, et al. Semisynthetic Derivatives of Polygodial as α-Glucosidase and α-Amylase Inhibitors: In Vitro Evaluation, Molecular Docking and Molecular Dynamics Simulation. Pharmaceutics. 2026;18(8):960. doi:10.3390/pharmaceutics18080960
BibTeX
@article{Burgos2026,
author = {Burgos, Viviana and Villegas, Cecilia and Sanzana, Carlos and Oporto, Benjamin and Schmidt, Bernd and Nchiozem-Ngnitedem, Vaderament-Alexe and Iqbal, Muhammad Javid and Paz, Cristian},
title = {Semisynthetic Derivatives of Polygodial as α-Glucosidase and α-Amylase Inhibitors: In Vitro Evaluation, Molecular Docking and Molecular Dynamics Simulation},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {8},
pages = {960},
doi = {10.3390/pharmaceutics18080960}
}
EUVIMED